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Endovascular treatment of obliterative
hepatocavopathy with inferior vena cava occlusion
and renal vein thrombosis
Charles S. Thompson, MD, Michael J. Cohen, MD, and Jon M. Wesley, MD, Orlando, Fla
We describe the endovascular treatment of an occlusion of the inferior vena cava (IVC) due to obliterative hepatocavopa-
thy with renal and iliac vein thrombosis. A 34-year-old man with nephrotic syndrome and hepatic dysfunction presented
to the hospital after a 3-month history of lower extremity swelling with an acute deterioration in his condition. Magnetic
resonance venography diagnosed a massive IVC occlusion with thrombosis of the entire IVC, iliac veins, and renal vein.
He was treated with thrombolysis, and a chronic occlusion of the infrahepatic IVC was discovered. After venous stenting
of the IVC and iliac veins, he dramatically improved. After 24 months, he remains symptom-free with a patent IVC and
iliac veins. ( J Vasc Surg 2006;44:206-9.)Inferior vena cava (IVC) occlusion and thrombosis is an
uncommon condition that arises from a variety of disease
conditions.1-3 Obliterative hepatocavopathy, or primary IVC
thrombosis, is a form of Budd-Chiari syndrome and may
result in chronic or acute inferior vena occlusion in conjunc-
tion with intrahepatic IVC stenosis.4,5 Patients usually present
with a variety of symptoms as a result of venous hypertension,
including lower extremity edema and liver dysfunction. Med-
ical therapy includes anticoagulation and compression, with
less than impressive results.6 Equally disappointing have been
the results of surgical treatments of IVC occlusion.7-9 Endo-
vascular therapies offer an alternative mode of therapy for
these complex patients.10-14 We present a case of massive
thrombotic occlusion of the IVC treated with endovascular
thrombolysis, angioplasty, and stenting.
CASE REPORT
A 34-year-old man with a history of hepatitis B, nephrolithia-
sis, nephrotic syndrome, and membranous glomerulonephropathy
presented with a 3-month history of lower extremity swelling. Five
days before admission, the swelling extended upward to his abdo-
men and back, and he began to complain of abdominal pain, flank
pain, and a feeling of dread. He was unable to flex his legs, and
walking was extremely painful. He was tachycardic, febrile, and
hypotensive. Results of liver function studies were elevated, as were
serum creatinine levels, and his total protein value was decreased.
Computed tomography (CT) and magnetic resonance imag-
ing of the venous system showed massive IVC and renal vein
thrombosis with complete lack of venous return (Fig 1). Contrast
venography confirmed a massive IVC and iliac vein thrombosis.
Access to both femoral veins and to both jugular veins was
obtained with sheaths. Thrombolysis catheters were placed into
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206the iliac veins, IVC, and renal veins. Catheter-directed thrombol-
ysis was performed with Alteplase (recombinant tissue-type plas-
minogen activator) over the course of 36 hours in the intensive care
unit at a total of 2 U/hour with full-dose heparin. Serial venogra-
phy showed gradual resolution of the clot in the iliac and renal
veins, but a large amount of thrombus remained in the IVC.
Angioplasty with 14-mm and 16-mm balloons of this area
failed to yield satisfactory results, andWallstents (Boston Scientific,
Natick, Mass) were deployed in the infrarenal IVC (16  80 mm
and 16 80 mm) and in the iliac veins (14 60 mm and 14 60
mm). Postprocedure CT venography of the abdomen was per-
formed by injecting contrast through the femoral sheaths and
imaging the IVC and iliac veins. A patent infrarenal IVC after
stenting was demonstrated (Fig 2), but an area of chronic throm-
bus and stenosis superior to the stents was seen at the suprarenal
and intrahepatic portion of the IVC (Fig 3).
Thrombolysis was continued, and the patientwas returned to the
endovascular suite 6 hours later. Intravascular ultrasound confirmed a
chronic stenosis of the suprarenal IVC and intrahepatic IVC stenosis
(Fig 4, A). Suprarenal IVC stenting was performed with Wallstents
(184mmand2080mm) to the level of the intrahepatic stenosis.
Intravascular ultrasound confirmed the resolution of the stenosis and
restoration of IVC patency (Fig 4, B).
The patient stabilized over the course of the next 72 hours. His
tachycardia and hypotension resolved, he diuresed large volumes of
urine, and the severe swelling resolved. His serum creatinine level
returned to normal, and the values for his serum liver function studies
decreased. He was placed on Coumadin (Bristol-Myers Squibb,
Princeton, NJ) anticoagulation. He was discharged from the hospital
and lost30 pounds of water weight over several weeks.
One year later, the patient had an episode of flank pain and leg
pain, and he was admitted to the hospital for nephrolithiasis.
Venography of the IVC and iliac veins was performed for surveil-
lance (Fig 5). All stents were patent. The patient remains asymp-
tomatic 2 years after the procedure.
DISCUSSION
Obliterative hepatocavopathy, a clinical entity also
known as Budd-Chiari syndrome, results in abdominal and
lower extremity venous hypertension. The former designa-
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and primary inferior vena cava thrombosis are terms differ-
entiating the pathology from hepatic vein thrombosis,
which primarily affects hepatic veins and liver function.
With obliterative hepatocavopathy, a membrane or stenosis
of the intrahepatic IVC causes obstruction. The stenotic
membrane of the intrahepatic portion of the IVC is
thought to be organized layers of chronic thrombus of
different ages. Hypercoagulability disorders are a common
association. Clinical onset is progressive and if untreated
can result in severe debilitating abdominal pain, back pain,
liver dysfunction, kidney dysfunction, lower extremity
Fig 1. A and B,Magnetic resonance venography of the
into the renal and iliac veins.
Fig 2. Computed tomography with venous contrast of the abdo-
men after thrombolysis and stenting of the infrarenal inferior vena
cava.weakness, and severe swelling.1-5Medical therapy of IVC occlusion has shown poor
results, and the results of surgical replacement of the infe-
rior vena cava with vein grafts has been disappointing.
Difficulties in treating IVC stenosis and occlusion surgically
stem from difficulties in identifying an adequate conduit,
poor patencies, and the need for secondary surgeries.7,8
Balloon angioplasty of venous stenosis may be of some
benefit in these patients. Long-term patency after angio-
plasty of large central veins has been poor, however, due to
the fibrotic nature of venous stenosis, vessel recoil, low flow
state, and thrombogenicity of the lumen.15,16 Stenting of
large-vein stenosis improves patency and outcome by pre-
venting elastic recoil. Although long-term results of venous
stenting are not well described, reports of patency5 years
exist. Reports of patients with IVC stents are sporadic
because the procedure is intensive, often complex, and not
well established. However, several reports have shown
short-term and mid-term primary patency rates of 70% to
80% with large-vessel venous stenting of increasingly diffi-
cult cases.10,13,17,18
Venous thrombosis is a known complication of ne-
phrotic syndrome and hypoproteinemia. Thrombosis of
the IVC is a rare complication of nephrotic syndrome.19 In
this patient, the symptoms of obliterative hepatocavopathy
were worsened by an acquired hypercoagulable state as a
result of his nephrotic syndrome. The actual onset of symp-
toms may not correlate with the initial thrombosis, and the
diagnosis was not suspected until late in the patient’s pre-
sentation. Worsening of his hypoproteinemia may have
precipitated the extension of the thrombosis to the iliac and
renal veins and occluded collateral pathways that compen-
sated for the initial IVC occlusion, creating the scenario of
ior vena cava shows occlusion with thrombus extendinginferhepatic and renal dysfunction with severe edema.
g intr
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been described.20 The failure of thrombolysis to com-
Fig 3. A, Computed tomography with venous contrast
B, Computed tomography with venous contrast showin
Fig 4. A, Intravascular ultrasound of the intrahepatic i
stenosis after treatment with Wallstents.
Fig 5. Digital subtraction venography of inferior vena cava 1 year
after the procedure shows widely patent stents.pletely correct the symptoms in this patient was due to thepresence of the chronic occlusion of the IVC. A strategy
that employed thrombolysis with angioplasty and stenting
was necessary to relieve the symptoms of renal and hepatic
dysfunction as well as severe lower extremity venous hyper-
tension. Although the durability of such procedures is
largely anecdotal, the patient remains with a satisfactory
result 2 years after the procedure, with patent venous stents
and no return of symptoms.
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